TAG1, Inc.

CDMO · United States

TAG1 aims to be a premier supplier of medical radioisotopes for Targeted Alpha Therapies (TAT) that will empower biotech innovators and healthcare institutions with the technology and partnerships needed to develop groundbreaking radiopharmaceutical therapies for patients worldwide. Source (opens in a new tab)

Headquarters: US
Provider types: API manufacturer